Background: The study objective was to find out how cost-covering the treatment of patients with a potentially severe injury actually is in a Swiss trauma center and to what extent hospital profits/losses correlate with patient-related accident, treatment and outcome variables.
Methods: Analysis of all patients hospitalized in a Swiss trauma center in 2018 following treatment in the emergency room (ER) and/or with a significant injury (new injury severity score, NISS ≥8). Hospital cost-benefit calculation using current Swiss diagnosis-related groups (DRG) and the REKOLE© billing system (univariate and multivariate analysis; p < 0.05).
Results: From a hospital point of view, the study cohort (n = 513; Ø NISS = 18) generated a deficit of 1.8 million CHF. This corresponded to a total coverage of 86%, with 66% of cases incurring a loss (71% of statutory insurance vs. 42% of privately insured; p < 0.001). On average, the deficit was 3493 CHF per patient (4545 CHF for statutory insurance vs. 1318 CHF for privately insured; p < 0.001), with a loss also in 63% of inliers and underliers (DRG). The ER cases more frequently caused a financial loss than non-ER cases (73% vs. 58%; p = 0.002) or traumatology vs. neurosurgery cases (72% vs. 55%; p < 0.001). In multivariable analysis 43% of the variance of financial returns were explained by the studied parameters. In contrast, only 11% (adjusted R) of the variance of the hospital cover ratio could be described by the variables ER, surgical specialty, intensive care, thoracic injury and hospital mortality. The case mix index (DRG) and type of insurance added a further 13% to a total of 24% explained variance.
Conclusion: From a Swiss trauma center point of view only one third of emergencies are not loss-making, most of all privately insured patients or cases billable via a combined polytrauma and head trauma DRG.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397679 | PMC |
http://dx.doi.org/10.1007/s00113-020-00937-w | DOI Listing |
Autophagy
October 2016
kb Emory University, School of Medicine, Department of Microbiology and Immunology , Atlanta , GA , USA.
J Endovasc Ther
February 2009
Clinical and Interventional Angiology, Swiss Cardiovascular Center, Inselspital, University Hospital Bern, Switzerland.
Endovascular aneurysm repair has matured significantly over the last 20 years and is becoming increasingly popular as a minimally invasive treatment option for patients with abdominal aortic aneurysms (AAA). Long-term durability of this fascinating treatment, however, is in doubt as continuing aneurysmal degeneration of the aortoiliac graft attachment zones is clearly associated with late adverse sequelae. In recent years, our growing understanding of the physiopathology of AAA formation has facilitated scrutiny of various potential drug treatment concepts.
View Article and Find Full Text PDFJ Endovasc Ther
April 2007
Division of Angiology, Swiss Cardiovascular Centre, University Hospital, (Inselspital), Bern, Switzerland.
Purpose: To elucidate the association of impaired pulmonary status (IPS) and diabetes mellitus (DM) with clinical outcome and the incidences of aortic neck dilatation and type I endoleak after elective endovascular infrarenal aortic aneurysm repair (EVAR).
Methods: In 164 European institutions participating in the EUROSTAR registry, 6383 patients (5985 men; mean age 72.4+/-7.
Swiss Surg
November 1999
Klinik für Herz- und Gefässchirurgie, Universitätsspital Zürich.
Aims: The endovascular repair of abdominal aortic aneurysms (AAA) is a minimally invasive method which can be performed without laparotomy, thoracotomy or cross-clamping. Little is known about the endovascular feasibility in patients with contained ruptures.
Methods: Retrospective study on 31 patients (mean age 70 +/- 6 years, 27 men (87.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!